The FLOW trial of semaglutide, the DANCAVAS C...
Clues in SCAF, a DOAC antidote trial, another...
An Impella update, another TAVI vs SAVR trial...
Inclisiran, sodium-channel blocker safety, an...
The DEDICATE trial of TAVR vs SAVR, more on r...
A listener defends colored boxes in guideline...
ACC Part 2: The TACT2 trial of chelation, int...
ACC Recap #1: DanGer Shock (plus a sobering J...
Statins and diabetes, AAD in patients with he...
Intermittent fasting, anticoagulation decisio...